期刊
ACS NANO
卷 11, 期 3, 页码 2313-2381出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.6b06040
关键词
-
类别
资金
- Deutscher Akademischer Austauschdienst (DAAD)
- Chinesisch Deutsches Zentrum far Wissenschaftsforderung (CDZ)
- Chinese Academy of Science (CAS)
- National Natural Science Foundation [51390481, 81227902, 81625011]
- National Basic Research Program of China [2014CB931900]
- European Commission
- Spanish Ministerio de Economia y Competitividad [CTQ2011-23167, CTQ2014-59808R]
- Generalitat of Catalunya [2014-SGR-612]
- Deutsche Forschungsgemeinschaft (DFG) [AL552/8-1]
- Swiss National Science Foundation [NRP62]
- Claude & Julianna Foundation
- National Science Foundation (NSF) [CHE-1306928, ECS-0601345, CBET 0933384, CBET 0932823, CBET 1036672]
- Canadian Institute of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Alexander von Humboldt Foundation
- Lars Hiertas Minne Foundation
- U.S. National Cancer Institute, NIH [U01CA198846]
- Junta de Andalucia (Spain)
- European Union [267226]
- BOF (UGent)
- FWO (Research Foundation Flanders)
- National Natural Science Foundation of China [81625011]
- ICREA Funding Source: Custom
The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest. Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many of these developments are starting to be translated into viable clinical products. Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据